Results 161 to 170 of about 114,692 (269)

Preoperative Glycosylated Hemoglobin A1C Impacts Long‐Term Outcomes Following Curative‐Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background To investigate the impact of preoperative glycosylated hemoglobin A1C (HbA1c) among patients following curative‐intent resection of nonfunctional gastroentropancreatic neuroendocrine tumors (GEP‐NETs). Methods Patients who underwent curative‐intent resection for GEP‐NETs from 2000 to 2020 were identified from the US Neuroendocrine ...
Mu‐Xing Li, Alexandra G. Lopez‐Aguiar, George Poultsides, Flavio Rocha, Sharon Weber, Ryan Fields, Kamran Idrees, Cliff Cho, Shishir K. Maithel, Xu‐Feng Zhang, Timothy M. Pawlik   +10 more
wiley   +1 more source

Blockade of glucagon receptor induces α-cell hypersecretion by hyperaminoacidemia in mice. [PDF]

Nat Commun
Jia J, Bai X, Kang Q, Jiang F, Wong FS, Jin Q, Li M.   +6 more
europepmc   +1 more source

STUDIES OF GLYCOGEN METABOLISM IN LIVER GLYCOGEN DISEASE (VON GIERKE'S DISEASE): SIX CASES WITH SIMILAR METABOLIC ABNORMALITIES AND RESPONSES TO GLUCAGON* [PDF]

, 1961
Joseph E. Sokal, Charles U. Lowe, Edward J. Sarcione, Luis L. Mosovich, B Doray   +4 more
openalex   +1 more source

Otolaryngologic Side Effects of GLP‐1 Receptor Agonists

The Laryngoscope, EarlyView.
Objectives With the increasing use of GLP‐1 receptor agonist (GLP‐1 RA) drugs for weight loss and diabetes management, concerns have been raised regarding their potential side effects. We aim to assess the frequency of otolaryngologic adverse events (AEs). Study Design Retrospective analysis of national registry.
Faizaan I. Khan, Sebastian Guadarrama‐Sistos Vazquez, Zain Mehdi, Isuru Somawardana, Roshan Dongre, Samuel Razmi, Keyvon Rashidi, Jason Shenoi, Najm Khan, Aatin Dhanda, Masayoshi Takashima, Omar G. Ahmed   +11 more
wiley   +1 more source

Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data. [PDF]

Curr Obes Rep
Anastasiou IΑ, Argyrakopoulou G, Dalamaga M, Kokkinos A.   +3 more
europepmc   +1 more source

Islet-cell metabolism during insulin release. Effects of glucose, citrate, octanoate, tolbutamide, glucagon and theophylline [PDF]

, 1969
W Montague, K. W. Taylor
openalex   +1 more source

Role of serum fasting glucagon in hypothyroidism-related nonalcoholic fatty liver disease. [PDF]

Nutr Metab (Lond)
El-Eshmawy MM, Barakat AA, El-Baiomy AA, El-Naga MMA, Elbasiony M.   +4 more
europepmc   +1 more source

The Inductions of Tyrosine Aminotransferase by Glucagon and Hydrocortisone

, 1967
Vilmos Csányi, Olga Greengard, W. Eugene Knox   +2 more
openalex   +1 more source

The physiological effect of glucagon on fat-mobilisation [PDF]

, 1966
Pierre Lefèbvre
openalex   +1 more source

The Gut‐Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications

Movement Disorders Clinical Practice, EarlyView.
Abstract Background The gut‐brain axis, i.e. the bidirectional communication system between the gut and the brain, has become of central importance in Parkinson disease (PD) research over the past 20 years. Aims We aimed to describe the milestones of the gut‐brain axis research in PD and the development of theories proposing the involvement of the ...
Elisa Menozzi, Anthony H.V. Schapira, Per Borghammer   +2 more
wiley   +1 more source